Arkolith/Insider Trading/ENTA/Form 4

Rottinghaus Scott T.

Chief Medical OfficerENANTA PHARMACEUTICALS INC (ENTA) · full profile →Form 4 · filed Aug 9, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 8, 2024Tax withholding(F)1K$12.73$19K19K
Aug 8, 2023Tax withholding(F)1K$17.23$25K26K

Transaction Codes

F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001062993-24-014792) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML